Carla J Weinheimer1, Attila Kovacs1, Sarah Evans1, Scot J Matkovich1, Philip M Barger1, Douglas L Mann2. 1. Center for Cardiovascular Research, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO. 2. Center for Cardiovascular Research, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO. dmann@wustl.edu.
Abstract
BACKGROUND: To better understand reverse left ventricular (LV) remodeling, we developed a murine model wherein mice develop LV remodeling after transverse aortic constriction (TAC) and a small apical myocardial infarct (MI) and undergo reverse LV remodeling after removal of the aortic band. METHODS AND RESULTS: Mice studied were subjected to sham (n=6) surgery or TAC+MI (n=12). Two weeks post-TAC+MI, 1 group underwent debanding (referred to as heart failure debanding [HF-DB] mice; n=6), whereas the aortic band remained in a second group (heart failure [HF] group; n=6). LV remodeling was evaluated by 2D echocardiography at 1 day, 2 weeks and 6 weeks post-TAC+MI. The hearts were analyzed by transcriptional profiling at 4 and 6 weeks and histologically at 6 weeks. Debanding normalized LV volumes, LV mass, and cardiac myocyte hypertrophy at 6 weeks in HF-DB mice, with no difference in myofibrillar collagen in the HF and HF-DB mice. LV ejection fraction and radial strain improved after debanding; however, both remained decreased in the HF-DB mice relative to sham and were not different from HF mice at 6 weeks. Hemodynamic unloading in the HF-DB mice was accompanied by a 35% normalization of the HF genes at 2 weeks and 80% of the HF genes at 4 weeks. CONCLUSIONS: Hemodynamic unloading of a pathophysiologically relevant mouse model of HF results in normalization of LV structure, incomplete recovery of LV function, and incomplete reversal of the HF transcriptional program. The HF-DB mouse model may provide novel insights into mechanisms of reverse LV remodeling.
BACKGROUND: To better understand reverse left ventricular (LV) remodeling, we developed a murine model wherein mice develop LV remodeling after transverse aortic constriction (TAC) and a small apical myocardial infarct (MI) and undergo reverse LV remodeling after removal of the aortic band. METHODS AND RESULTS:Mice studied were subjected to sham (n=6) surgery or TAC+MI (n=12). Two weeks post-TAC+MI, 1 group underwent debanding (referred to as heart failure debanding [HF-DB] mice; n=6), whereas the aortic band remained in a second group (heart failure [HF] group; n=6). LV remodeling was evaluated by 2D echocardiography at 1 day, 2 weeks and 6 weeks post-TAC+MI. The hearts were analyzed by transcriptional profiling at 4 and 6 weeks and histologically at 6 weeks. Debanding normalized LV volumes, LV mass, and cardiac myocyte hypertrophy at 6 weeks in HF-DB mice, with no difference in myofibrillar collagen in the HF and HF-DB mice. LV ejection fraction and radial strain improved after debanding; however, both remained decreased in the HF-DB mice relative to sham and were not different from HF mice at 6 weeks. Hemodynamic unloading in the HF-DB mice was accompanied by a 35% normalization of the HF genes at 2 weeks and 80% of the HF genes at 4 weeks. CONCLUSIONS: Hemodynamic unloading of a pathophysiologically relevant mouse model of HF results in normalization of LV structure, incomplete recovery of LV function, and incomplete reversal of the HF transcriptional program. The HF-DB mouse model may provide novel insights into mechanisms of reverse LV remodeling.
Authors: Sunitha Rangaraju; Gregory M Solis; Ryan C Thompson; Rafael L Gomez-Amaro; Leo Kurian; Sandra E Encalada; Alexander B Niculescu; Daniel R Salomon; Michael Petrascheck Journal: Elife Date: 2015-12-01 Impact factor: 8.140
Authors: Ravi V Desai; Mustafa I Ahmed; Marjan Mujib; Inmaculada B Aban; Michael R Zile; Ali Ahmed Journal: Am J Cardiol Date: 2010-12-02 Impact factor: 2.778
Authors: Veli K Topkara; Kari T Chambers; Kai-Chien Yang; Huei-Ping Tzeng; Sarah Evans; Carla Weinheimer; Attila Kovacs; Jeffrey Robbins; Philip Barger; Douglas L Mann Journal: JCI Insight Date: 2016-04-06
Authors: Luigi Adamo; Andrew Perry; Eric Novak; Majesh Makan; Brian R Lindman; Douglas L Mann Journal: Circ Heart Fail Date: 2017-06 Impact factor: 8.790
Authors: A Mark Richards; M Gary Nicholls; Richard W Troughton; John G Lainchbury; John Elliott; Christopher Frampton; Eric A Espiner; Ian G Crozier; Timothy G Yandle; John Turner Journal: J Am Coll Cardiol Date: 2002-04-03 Impact factor: 24.094
Authors: Lily S Neff; Yuhua Zhang; An O Van Laer; Catalin F Baicu; Mark Karavan; Michael R Zile; Amy D Bradshaw Journal: Am J Physiol Heart Circ Physiol Date: 2022-06-03 Impact factor: 5.125
Authors: Jacek Kwiecinski; Ross J Lennen; Gillian A Gray; Gary Borthwick; Lyndsey Boswell; Andrew H Baker; David E Newby; Marc R Dweck; Maurits A Jansen Journal: J Cardiovasc Magn Reson Date: 2020-08-06 Impact factor: 5.364
Authors: Kyle S McCommis; Attila Kovacs; Carla J Weinheimer; Trevor M Shew; Timothy R Koves; Olga R Ilkayeva; Dakota R Kamm; Kelly D Pyles; M Todd King; Richard L Veech; Brian J DeBosch; Deborah M Muoio; Richard W Gross; Brian N Finck Journal: Nat Metab Date: 2020-10-26